Hypocretin (orexin) regulation of sleep-to-wake transitions

Frontiers in Pharmacology

Volumn 5 FEB, Issue , 2014, Pages

  de Lecea, Luis ^a   Huerta, Ramón ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hypervigilance avoidance; Hypothalamus; Optogenetics; Orexin; Sleep

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CHOLECYSTOKININ; GHRELIN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE Y; NICOTINIC RECEPTOR; NORADRENALIN; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; SEROTONIN;

ALZHEIMER DISEASE; ANXIETY DISORDER; CIRCADIAN RHYTHM; DEPRESSION; HUMAN; INFORMATION PROCESSING; INTRACELLULAR RECORDING; LIGHT DARK CYCLE; LIMBIC SYSTEM; METABOLIC ACTIVATION; NERVE CELL; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; NONREM SLEEP; OPTOGENETICS; PANIC; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHASE TRANSITION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; REM SLEEP; REVIEW; SLEEP WAKING CYCLE; WAKEFULNESS;

EID: 84895531538     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00016     Document Type: Review

References (96)

1. Adamantidis, A., and de Lecea, L. (2008a). Physiological arousal: a role for hypothalamic systems. Cell. Mol. Life. Sci. 65, 1475-1488. doi: 10.1007/s00018-008-7521-8.
2. Adamantidis, A., and de Lecea, L. (2008b). Sleep and metabolism: shared circuits, new connections. Trends Endocrinol. Metab. 19, 362-370. doi: 10.1016/j.tem.2008.08.007.
3. Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., and De Lecea, L. (2007). Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450, 420-424. doi: 10.1038/nature06310.
4. Appelbaum, L., Wang, G., Yokogawa, T., Skariah, G. M., Smith, S. J., Mourrain, P., et al. (2010). Circadian and homeostatic regulation of structural synaptic plasticity in hypocretin neurons. Neuron 68, 87-98. doi: 10.1016/j.neuron.2010.09.006.
5. Arrigoni, E., Mochizuki, T., and Scammell, T. E. (2010). Activation of the basal forebrain by the orexin/hypocretin neurones. Acta physiol. 198, 223-235. doi: 10.1111/j.1748-1716.2009.02036.x.
6. Asai, H., Hirano, M., Furiya, Y., Kanbayashi, T., Ikeda, M., Kiriyama, T., et al. (2008). Cerebrospinal fluid orexin and sleep attacks in Parkinson disease. Ann. Neurol. 64, S50-S51.
7. Baumann, C. R., Scammell, T. E., and Bassetti, C. L. (2008). Parkinson's disease, sleepiness and hypocretin/orexin. Brain 131, e91. doi: 10.1093/brain/awm220.
8. Bayer, L., Eggermann, E., Serafin, M., Grivel, J., Machard, D., Muhlethaler, M., et al. (2005). Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices. Neuroscience 130, 807-811. doi: 10.1016/j.neuroscience.2004.10.032.
9. Bayer, L., Eggermann, E., Serafin, M., Saint-Mleux, B., Machard, D., Jones, B., et al. (2001). Orexins (hypocretins) directly excite tuberomammillary neurons. Eur. J. Neurosci. 14, 1571-1575. doi: 10.1046/j.0953-816x.2001.01777.x.
10. Borgland, S. L., and Labouebe, G. (2010). Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential. Neuropsychopharmacology 35, 353-354. doi: 10.1038/npp.2009.119.
11. Bourgin, P., Huitron-Resendiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., et al. (2000). Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci. 20, 7760-7765.
12. Burlet, S., Tyler, C. J., and Leonard, C. S. (2002). Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J. Neurosci. 22, 2862-2872.
13. Carter, M. E., Adamantidis, A., Ohtsu, H., Deisseroth, K., and De Lecea, L. (2009a). Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J. Neurosci. 29, 10939-10949. doi: 10.1523/JNEUROSCI.1205-09.2009.
14. Carter, M. E., Adamantidis, A., Ohtsu, H., Deisseroth, K., and De Lecea, L. (2009b). Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J. Neurosci. 29, 10939-10949. doi: 10.1523/JNEUROSCI.1205-09.2009.
15. Carter, M. E., Brill, J., Bonnavion, P., Huguenard, J. R., Huerta, R., and De Lecea, L. (2012). Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc. Natl. Acad. Sci. U.S.A. 109, E2635-E2644. doi: 10.1073/pnas.1202526109.
16. Carter, M. E., Yizhar, O., Chikahisa, S., Nguyen, H., Adamantidis, A., Nishino, S., et al. (2010). Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat. Neurosci. 13, 1526-1533. doi: 10.1038/nn.2682.
17. Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., et al. (1999). Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451. doi: 10.1016/S0092-8674(00)81973-X.
18. Crocker, A., Espana, R. A., Papadopoulou, M., Saper, C. B., Faraco, J., Sakurai, T., et al. (2005). Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65, 1184-1188. doi: 10.1212/01.wnl.0000168173.71940.ab.
19. De la Herran-Arita, A. K., Kornum, B. R., Mahlios, J., Jiang, W., Lin, L., Hou, T., et al. (2013). CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza a epitope in narcolepsy. Sci. Transl. Med. 5, 216ra176. doi: 10.1126/scitranslmed.3007762.
20. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., et al. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95, 322-327. doi: 10.1073/pnas.95.1.322.
21. Deboer, T., Overeem, S., Visser, N. A., Duindam, H., Frolich, M., Lammers, G. J., et al. (2004). Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 129, 727-732. doi: 10.1016/j.neuroscience.2004.07.049.
22. Deurveilher, S., and Semba, K. (2005). Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: Implications for the circadian control of behavioural state. Neuroscience 130, 165-183. doi: 10.1016/j.neuroscience.2004.08.030.
23. Drouot, X., Moutereau, S., Nguyen, J. P., Lefaucheur, J. P., Creange, A., Remy, P., et al. (2003). Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61, 540-543. doi: 10.1212/01.WNL.0000078194.53210.48.
24. Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., et al. (2009). Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J. Pharmacol. Exp. Ther. 330, 142-151. doi: 10.1124/jpet.109.152009.
25. Eriksson, K. S., Sergeeva, O., Brown, R. E., and Haas, H. L. (2001). Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21, 9273-9279.
26. Espana, R. A., Baldo, B. A., Kelley, A. E., and Berridge, C. W. (2001). Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106, 699-715. doi: 10.1016/S0306-4522(01)00319-0.
27. Estabrooke, I. V., Mccarthy, M. T., Ko, E., Chou, T. C., Chemelli, R. M., Yanagisawa, M., et al. (2001). Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656-1662.
28. Fronczek, R., Overeem, S., Lee, S. Y., Hegeman, I. M., Van Pelt, J., Van Duinen, S. G., et al. (2008). Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease. Brain 131, e88. doi: 10.1093/brain/awm222.
29. Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E., and Nishino, S. (2001). Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12, 993-997. doi: 10.1097/00001756-200104170-00026.
30. Gozzi, A., Turrini, G., Piccoli, L., Massagrande, M., Amantini, D., Antolini, M., et al. (2011). Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 6:e16406. doi: 10.1371/journal.pone.0016406.
31. Grivel, J., Cvetkovic, V., Bayer, L., Machard, D., Tobler, I., Muhlethaler, M., et al. (2005). The wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J. Neurosci. 25, 4127-4130. doi: 10.1523/JNEUROSCI.0666-05.2005.
32. Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., et al. (1999). Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 96, 10911-10916. doi: 10.1073/pnas.96.19.10911.
33. Hassani, O. K., Lee, M. G., and Jones, B. E. (2009). Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc. Natl. Acad. Sci. U.S.A. 106, 2418-2422. doi: 10.1073/pnas.0811400106.
34. Herring, W. J., Snyder, E., Budd, K., Hutzelmann, J., Snavely, D., Liu, K., et al. (2012). Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 79, 2265-2274. doi: 10.1212/WNL.0b013e31827688ee.
35. Hondo, M., Nagai, K., Ohno, K., Kisanuki, Y., Willie, J. T., Watanabe, T., et al. (2010). Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states. Acta physiol. 198, 287-294. doi: 10.1111/j.1748-1716.2009.02032.x.
36. Horvath, T. L., and Gao, X. B. (2005). Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab. 1, 279-286. doi: 10.1016/j.cmet.2005.03.003.
37. Huang, Z. L., Qu, W. M., Li, W. D., Mochizuki, T., Eguchi, N., Watanabe, T., et al. (2001). Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U.S.A. 98, 9965-9970. doi: 10.1073/pnas.181330998.
38. Inutsuka, A., and Yamanaka, A. (2013). The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. Front. Endocrinol. 4:18. doi: 10.3389/fendo.2013.00018.
39. Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., et al. (2010). A key role for orexin in panic anxiety. Nat. Med. 16, 111-115. doi: 10.1038/nm.2075.
40. Kang, J. E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007. doi: 10.1126/science.1180962.
41. Kaur, S., Thankachan, S., Begum, S., Liu, M., Blanco-Centurion, C., and Shiromani, P. J. (2009). Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice. PLoS ONE 4:e6346. doi: 10.1371/journal.pone.0006346.
42. Kohlmeier, K. A., Watanabe, S., Tyler, C. J., Burlet, S., and Leonard, C. S. (2008). Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J. Neurophysiol. 100, 2265-2281. doi: 10.1152/jn.01388.2007.
43. Kumar, S., Szymusiak, R., Bashir, T., Rai, S., Mcginty, D., and Alam, M. N. (2007). Effects of serotonin on perifornical-lateral hypothalamic area neurons in rat. Eur. J. Neurosci. 25, 201-212. doi: 10.1111/j.1460-9568.2006.05268.x.
44. Lee, M. G., Hassani, O. K., and Jones, B. E. (2005). Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25, 6716-6720. doi: 10.1523/JNEUROSCI.1887-05.2005.
45. Leinninger, G. M., Opland, D. M., Jo, Y. H., Faouzi, M., Christensen, L., Cappellucci, L. A., et al. (2011). Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metab. 14, 313-323. doi: 10.1016/j.cmet.2011.06.016.
46. Li, Y., Gao, X. B., Sakurai, T., and Van Den Pol, A. N. (2002). Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36, 1169-1181. doi: 10.1016/S0896-6273(02)01132-7.
47. Lin, J. S., Sergeeva, O. A., and Haas, H. L. (2011). Histamine H3 receptors and sleep-wake regulation. J. Pharmacol. Exp. Ther. 336, 17-23. doi: 10.1124/jpet.110.170134.
48. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., et al. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365-376. doi: 10.1016/S0092-8674(00)81965-0.
49. Liu, R. J., Van Den Pol, A. N., and Aghajanian, G. K. (2002). Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 22, 9453-9464.
50. Louis, G. W., Leinninger, G. M., Rhodes, C. J., and Myers, M. G. Jr. (2010). Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons. J. Neurosci. 30, 11278-11287. doi: 10.1523/JNEUROSCI.1340-10.2010.
51. Lu, J., and Greco, M. A. (2006). Sleep circuitry and the hypnotic mechanism of GABAA drugs. J. Clin. Sleep Med. 2, S19-S26.
52. Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., et al. (2001). Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6-25. doi: 10.1002/cne.1190.
53. Methippara, M. M., Alam, M. N., Szymusiak, R., and Mcginty, D. (2000). Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 11, 3423-3426. doi: 10.1097/00001756-200011090-00004.
54. Mieda, M., Hasegawa, E., Kisanuki, Y. Y., Sinton, C. M., Yanagisawa, M., and Sakurai, T. (2011). Differential roles of orexin receptor-1 and-2 in the regulation of non-REM and REM sleep. J. Neurosci. 31, 6518-6526. doi: 10.1523/JNEUROSCI.6506-10.2011.
55. Mileykovskiy, B. Y., Kiyashchenko, L. I., and Siegel, J. M. (2005). Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787-798. doi: 10.1016/j.neuron.2005.04.035.
56. Mochizuki, T., Arrigoni, E., Marcus, J. N., Clark, E. L., Yamamoto, M., Honer, M., et al. (2011). Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc. Natl. Acad. Sci. U.S.A. 108, 4471-4476. doi: 10.1073/pnas.1012456108.
57. Mochizuki, T., Crocker, A., Mccormack, S., Yanagisawa, M., Sakurai, T., and Scammell, T. E. (2004). Behavioral state instability in orexin knock-out mice. J. Neurosci. 24, 6291-6300. doi: 10.1523/JNEUROSCI.0586-04.2004.
58. Monti, J. M. (2010a). The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep Med. Rev. 14, 319-327. doi: 10.1016/j.smrv.2009.10.003.
59. Monti, J. M. (2010b). The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness. Sleep Med. Rev. 14, 307-317. doi: 10.1016/j.smrv.2009.11.004.
60. Morairty, S. R., Dittrich, L., Pasumarthi, R. K., Valladao, D., Heiss, J. E., Gerashchenko, D., et al. (2013). A role for cortical nNOS/NK1 neurons in coupling homeostatic sleep drive to EEG slow wave activity. Proc. Natl. Acad. Sci. U.S.A. 110, 20272-20277. doi: 10.1073/pnas.1314762110.
61. Nishino, S., Fujiki, N., Ripley, B., Sakurai, E., Kato, M., Watanabe, T., et al. (2001). Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci. Lett. 313, 125-128. doi: 10.1016/S0304-3940(01)02270-4.
62. Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., and Mignot, E. (2000). Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39-40. doi: 10.1016/S0140-6736(99)05582-8.
63. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., et al. (2000). A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991-997. doi: 10.1038/79690.
64. Peyron, C., Tighe, D. K., Van Den Pol, A. N., De Lecea, L., Heller, H. C., Sutcliffe, J. G., et al. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996-10015.
65. Piper, D. C., Upton, N., Smith, M. I., and Hunter, A. J. (2000). The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12, 726-730. doi: 10.1046/j.1460-9568.2000.00919.x.
66. Rao, Y., Lu, M., Ge, F., Marsh, D. J., Qian, S., Wang, A. H., et al. (2008). Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. J. Neurosci. 28, 9101-9110. doi: 10.1523/JNEUROSCI.1766-08.2008.
67. Sakurai, T. (2007). The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8, 171-181. doi: 10.1038/nrn2092.
68. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585. doi: 10.1016/S0092-8674(00)80949-6.
69. Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., et al. (2005). Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46, 297-308. doi: 10.1016/j.neuron.2005.03.010.
70. Salomon, R. M., Ripley, B., Kennedy, J. S., Johnson, B., Schmidt, D., Zeitzer, J. M., et al. (2003). Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96-104. doi: 10.1016/S0006-3223(02)01740-7.
71. Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J., and Scammell, T. E. (2010). Sleep state switching. Neuron 68, 1023-1042. doi: 10.1016/j.neuron.2010.11.032.
72. Saper, C. B., Scammell, T. E., and Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature 437, 1257-1263. doi: 10.1038/nature04284.
73. Sasaki, K., Suzuki, M., Mieda, M., Tsujino, N., Roth, B., and Sakurai, T. (2011). Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS ONE 6:e20360. doi: 10.1371/journal.pone.0020360.
74. Scammell, T. E., Matheson, J. K., Honda, M., Thannickal, T. C., and Siegel, J. M. (2012). Coexistence of narcolepsy and Alzheimer's disease. Neurobiol. Aging 33, 1318-1319. doi: 10.1016/j.neurobiolaging.2010.12.008.
75. Schone, C., Cao, Z. F., Apergis-Schoute, J., Adamantidis, A., Sakurai, T., and Burdakov, D. (2012). Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J. Neurosci. 32, 12437-12443. doi: 10.1523/JNEUROSCI.0706-12.2012.
76. Scott, M. M., Marcus, J. N., Pettersen, A., Birnbaum, S. G., Mochizuki, T., Scammell, T. E., et al. (2011). Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 222, 289-294. doi: 10.1016/j.bbr.2011.02.044.
77. Simon, C., Kezunovic, N., Ye, M., Hyde, J., Hayar, A., Williams, D. K., et al. (2010). Gamma band unit activity and population responses in the pedunculopontine nucleus. J. Neurophysiol. 104, 463-474. doi: 10.1152/jn.00242.2010.
78. Steriade, M. (2003). The corticothalamic system in sleep. Front. Biosci. 8:d878-d899. doi: 10.2741/1043.
79. Steriade, M., and McCarley, R. (1990). Brainstem Control of Wakefulness and Sleep. New York: Plenum. doi: 10.1007/978-1-4757-4669-3.
80. Steriade, M., Mccormick, D. A., and Sejnowski, T. J. (1993). Thalamocortical oscillations in the sleeping and aroused brain. Science 262, 679-685. doi: 10.1126/science.8235588.
81. Sutcliffe, J. G., and de Lecea, L. (2002). The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3, 339-349. doi: 10.1038/nrn808.
82. Thakkar, M. M., Ramesh, V., Strecker, R. E., and Mccarley, R. W. (2001). Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139, 313-328.
83. Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., et al. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469-474. doi: 10.1016/S0896-6273(00)00058-1.
84. Tsujino, N., and Sakurai, T. (2009). Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 61, 162-176. doi: 10.1124/pr.109.001321.
85. Tsunematsu, T., Kilduff, T. S., Boyden, E. S., Takahashi, S., Tominaga, M., and Yamanaka, A. (2011). Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J. Neurosci. 31, 10529-10539. doi: 10.1523/JNEUROSCI.0784-11.2011.
86. Vetrivelan, R., Qiu, M. H., Chang, C., and Lu, J. (2010). Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance. Front. Neuroanat. 4:145. doi: 10.3389/fnana.2010.00145.
87. Willie, J. T., Chemelli, R. M., Sinton, C. M., Tokita, S., Williams, S. C., Kisanuki, Y. Y., et al. (2003). Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715-730. doi: 10.1016/S0896-6273(03)00330-1.
88. Willie, J. T., Chemelli, R. M., Sinton, C. M., and Yanagisawa, M. (2001). To eat or to sleep? orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24, 429-458. doi: 10.1146/annurev.neuro.24.1.429.
89. Winsky-Sommerer, R., Yamanaka, A., Diano, S., Borok, E., Roberts, A. J., Sakurai, T., et al. (2004). Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24, 11439-11448. doi: 10.1523/JNEUROSCI.3459-04.2004.
90. Xi, M. C., Morales, F. R., and Chase, M. H. (2001). Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res. 901, 259-264. doi: 10.1016/S0006-8993(01)02317-4.
91. Yamanaka, A., Muraki, Y., Ichiki, K., Tsujino, N., Kilduff, T. S., Goto, K., et al. (2006). Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol. 96, 284-298. doi: 10.1152/jn.01361.2005.
92. Yamanaka, A., Muraki, Y., Tsujino, N., Goto, K., and Sakurai, T. (2003). Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun. 303, 120-129. doi: 10.1016/S0006-291X(03)00299-7.
93. Yamanaka, A., Tabuchi, S., Tsunematsu, T., Fukazawa, Y., and Tominaga, M. (2010). Orexin directly excites orexin neurons through orexin 2 receptor. J. Neurosci. 30, 12642-12652. doi: 10.1523/JNEUROSCI.2120-10.2010.
94. Yoshida, K., Mccormack, S., Espana, R. A., Crocker, A., and Scammell, T. E. (2006). Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 494, 845-861. doi: 10.1002/cne.20859.
95. Yoshida, Y., Fujiki, N., Nakajima, T., Ripley, B., Matsumura, H., Yoneda, H., et al. (2001). Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075-1081. doi: 10.1046/j.0953-816x.2001.01725.x.
96. Zeitzer, J. M., Buckmaster, C. L., Parker, K. J., Hauck, C. M., Lyons, D. M., and Mignot, E. (2003). Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J. Neurosci. 23, 3555-3560.